RNA Formulation Solutions

  1. Small is Powerful

    Explore best-in-class nanoforming services and how this company works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting.

  2. pDNA Lipid Nanoparticle Formulation And Screening Using Nova IJM 1/24/2024

    Explore a platform designed to evaluate the effects of formulation and process parameters on the characteristics of DNA+LNP nanoparticles.

  3. Automated Screening System For Lipid Nanoparticle Formulation 12/6/2024

    Transform your LNP formulation research with the IJM NanoScaler Pro, an automated screening system designed to accelerate your research and ensure the stability of your LNP samples.

  4. Complete Solutions For Every Step Of Pharmaceutical Development 1/12/2023

    By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

  5. T Cell Kit For mRNA On NanoAssemblr Spark 4/14/2022

    The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.

  6. Customized Skid For Large Production Scale: IJM NanoProducer 12/9/2024

    The Impingement Jets Mixing (IJM) Large Production Scale Units are designed for high-flow production of nanoparticles (LNP, micro-emulsions, etc) and can be configured with up to eight parallel mixing units depending on customer requirements.

  7. mRNA/LNP Development And Manufacturing Services

    Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.

  8. Labscale Lipid Nanoparticle Production: IJM NanoScaler 12/9/2024

    The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.

  9. Oligonucleotides & Peptides

    Our expert team of 120 process chemists and 50 analytical chemists deliver process chemistry experience, formulation, analytical expertise and regulatory insight to meet your oligonucleotide and peptide needs.

  10. Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation 7/13/2023

    LipidBrick® IM21.7c

    •  Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
    •  Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
    •  Accelerate your project: in vitro and in vivo proof of concept have been successfully performed